MT-251

· Mirador Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT-251, covering 2026-02-25 to 2026-02-25. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-Human Single and Multiple Ascending Dose Study of MT-251 [Phase 1]